CARsgen Therapeutics

CARsgen Therapeutics

CARsgen Therapeutics

CARsgen is a leading immunotherapy company focused on the development of new chimeric antigen receptor
Founded
2014
Follow us
Alexa global traffic share
Latest funding
Undisclosed amount
Venture capital (Series A) - 2014
Team Size
1–10
Employees
Location
Headquarters
DealStreetAsia

Chinese biopharmaceutical firm CARsgen bags $186m Series C led by Loyal Valley